Melguizo Alonso, Consolación Author
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer
- Jiménez-López J.
- El-Hammadi M.
- Ortiz R.
- Cayero-Otero M.
- Cabeza L.
- Perazzoli G.
- Martin-Banderas L.
- Baeyens J.
- Prados J.
- Melguizo C.
PHARMACOLOGICAL RESEARCH - 1/3/2019
- SJR Quartile: Q1
- JCR Impact Factor: 5.893 (2019)
- CiteScore: 10.1 (2020)
- SJR: 1.609 (2019
- SNIP: 1.483 (2019
- JCR 5-year Impact Factor: 5.631
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
Evaluation of Novel Doxorubicin-Loaded Magnetic Wax Nanocomposite Vehicles as Cancer Combinatorial Therapy Agents
- Jimenez-Lopez, Julia
- Garcia-Hevia, Lorena
- Melguizo, Consolacion
- Prados, Jose
- Banobre-Lopez, Manuel
- Gallo, Juan
Pharmaceutics - 1/07/2020
- JCR Impact Factor: 6.321 (2020)
- JCR 5-year Impact Factor: 6.734
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study
- Jabalera Y.
- Garcia-Pinel B.
- Ortiz R.
- Iglesias G.
- Cabeza L.
- Prados J.
- Jimenez-Lopez C.
- Melguizo C.
Pharmaceutics - 1/8/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.421 (2019)
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Biomimetic magnetoliposomes as oxaliplatin nanocarriers: In vitro study for potential application in colon cancer
- Garcia-Pinel B.
- Jabalera Y.
- Ortiz R.
- Cabeza L.
- Jimenez-Lopez C.
- Melguizo C.
- Prados J.
Pharmaceutics - 1/6/2020
- JCR Impact Factor: 6.321 (2020)
- JCR 5-year Impact Factor: 6.734
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag<sub>2</sub>S and PLGA@Ag<sub>2</sub>S@SPION Nanocarriers with Drug Release Capability
- Alexis Alvear-Jiménez
- Irene Zabala Gutierrez
- Yingli Shen
- Gonzalo Villaverde
- Laura Lozano-Chamizo
- Pablo Guardia
- Miguel Tinoco
- Beatriz Garcia-Pinel
- Jose Prados
- Consolación Melguizo Alonso
- JUAN MANUEL LOPEZ-ROMERO
- Daniel Jaque
- Marco Filice
- Rafael Contreras-Caceres
Pharmaceutics - 1/01/2022
- JCR Impact Factor: 5.4 (2022)
- JCR 5-year Impact Factor: 6
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
In Vitro Efficacy of Extracts and Isolated Bioactive Compounds from Ascomycota Fungi in the Treatment of Colorectal Cancer: A Systematic Review
- Cristina Luque
- Ana Cepero
- Gloria Perazzoli
- Cristina Mesas
- Francisco Quiñonero
- Laura Cabeza
- Jose Prados
- Consolación Melguizo
Pharmaceuticals - 23/12/2022
- JCR Impact Factor: 4.6 (2022)
- JCR 5-year Impact Factor: 4.9
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Creatine kinase isoenzymes as markers of differentiation in rhabdomyosarcoma cells in culture
- FERNANDEZ, JE
- PRADOS, J
- MELGUIZO, C
- RODRIGUEZ, F
- ALVAREZ, L
- ARANEGA, A
Pathology Research and Practice - 1/12/1994
- CiteScore: 3.6 (2020)
- Scopus
- ORCID
- Web of Science
Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD
- Melguizo, C
- Prados, J
- Marchal, JA
- Aranega, AE
- Alvarez, L
- Aranega, A
Pathology Research and Practice - 1/02/1996
- JCR Impact Factor: 2.05 (2022)
- Category normalized Impact: 0.305 (1996)
- CiteScore: 3.6 (2020)
- Scopus
- ORCID
- Web of Science
Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: Correlation with clinical stage, tumor thickness and histological type
- Carrillo, E
- Prados, J
- Melguizo, C
- Marchal, JA
- Velez, C
- Serrano, S
- Boulaiz, H
- Merida, JA
- Aranega, A
Pathology International - 13/04/2002
10.1046/j.1440-1827.2002.01344.x
- JCR Quartile: Q3 (2002)
- SJR Quartile: Q1
- JCR Impact Factor: 0.935 (2022)
- Category normalized Impact: 0.231 (2002)
- CiteScore: 3 (2020)
- SJR: 0.461 (2002
- SNIP: 0.699 (2002
- SJR Categories: Medicine (miscellaneous) (Q1); Pathology and Forensic Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
This author has no conferences.
This author has no patents.
Magnetic nanoparticles with on-site azide and alkyne functionalized polymer coating in a single step through a solvothermal process
10.20944/preprints202407.2363.v1
- ORCID
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- JCR Impact Factor: 4.9 (2023)
- JCR 5-year Impact Factor: 5.5
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador